Finance
Markets
No recent trading data. The last price we hold for ALGN is from Jun 3 (48 days ago). This symbol may be delisted, renamed, or halted — the figures below reflect its last active session, not the current market.

ALGN

stock Healthcare Medical Instruments & Supplies
Align Technology
$161.71 -4.98 (-2.99%) Delayed · quoted 46d ago
Mixed 44% Slipping

What the indicators say

Mixed 3 of 5 trend signals bullish
Momentum · RSI 14 Leaning bearish
42
0oversold 30overbought 70100

RSI 42 — soft momentum, not yet oversold.

EMA 21 $167.49
Below
Near-term trend is down
SMA 50 $173.43
Below
Medium-term trend is down
SMA 200 $158.43
Above
Long-term trend is up
50 / 200-day
Golden cross
50-day above the 200-day — bullish
Supertrend $155.03
Uptrend
Price is holding above the Supertrend band — bullish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jun 3

The day open and close within the day's range
Low $160.70 High $167.12
Open
$161.71
-2.99%
Close
$161.71
-2.99%
52-week range where the price sits across its year
52w low $122.00 52w high $208.31
Current
$161.71
Prev close
$166.69
Volume 0.83× the 3-month average
0 avg 2× avg
Today
952.52K
3-mo avg
1.14M

Earningscalendar synced from Yahoo 57d ago

Most recent
Apr 2983 days ago
Next expected
Jul 29in 8 days

Recent earnings dates

  • Apr 29 83 days ago
  • Feb 4 167 days ago
  • Oct 29, 2025 265 days ago
  • Jul 30, 2025 356 days ago

Past earnings dates come from ALGN’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 51d ago

Fair

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), ALGN’s fundamentals read as fair overall.

P/E ratio Fair
27.2x

At 27.2x, investors are paying up; a fair amount of future growth is already in the price.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Fair
0.00%

This company pays no dividend, common for firms reinvesting their profits back into growth.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Fair
10.2%

A 10.2% margin is solid, in the ordinary range for a profitable company.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Fair
10.1%

A 10.1% return on equity is respectable, in the normal range.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Fair
6.6%

A 6.6% return on assets is reasonable for a company of this kind.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity Strong
0.54

At 0.54, the company carries less in liabilities than in equity, a conservative balance sheet.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Fair
1.36

At 1.36, short-term assets cover short-term bills with a little room to spare.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Fair
+0.9%

Revenue grew 0.9% from the prior year: steady, modest expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Weak
-2.6%

Net income fell 2.6% from the prior year; profit is shrinking.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 51d ago

FY2021FY2022FY2023FY2024FY2025
Revenue $4.0B$3.7B$3.9B$4.0B$4.0B
Net income $772.0M$361.6M$445.1M$421.4M$410.4M
Diluted EPS $9.69$4.61$5.81$5.62$5.65
Dividend / share
Total assets $5.9B$5.9B$6.1B$6.2B$6.2B
Total liabilities $2.3B$2.3B$2.5B$2.4B$2.2B
Shareholder equity $3.6B$3.6B$3.6B$3.9B$4.0B

Leadershipsynced from SEC 58d ago

  • Hogan Joseph M President and CEO · Director
  • Morici John EVP, CHIEF FINANCIAL OFFICER
  • Coletti Julie Ann EVP, CHIEF LEGAL & REGULATORY
  • Hockridge Stuart A EVP, GLOBAL HR
  • Marree Jitse See Remarks
  • Richardson Jaime Holte See Remarks
  • Conroy Kevin T Director
  • Dallas Kevin J Director
  • Lacob Joseph Director
  • Larkin C Raymond Jr Director
  • Morrow George J Director
  • Myong Anne Director
  • Poul Mojdeh Director
  • Saia Andrea Lynn Director
  • Siegel Susan E Director
  • Vitalone Britt J. Director

Officers and board are drawn from ALGN’s recent SEC ownership filings (Forms 3, 4 and 5).

Notable recent eventspast year

  • May 28 +6.4% one-day move
  • Apr 8 +6.0% one-day move
  • Mar 27 −6.2% one-day move
  • Feb 12 −6.9% one-day move
  • Feb 6 +6.8% one-day move
  • Feb 5 +8.9% one-day move
  • Sep 23, 2025 New 6-month low (-38% off peak)
  • Sep 18, 2025 Officer or director change reported in an 8-K
  • Jul 31, 2025 New 6-month low (-43% off peak)
  • Jul 31, 2025 −36.6% one-day move

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Recent SEC filingssynced from SEC 51d ago